Confidential Abbreviated Title: Phase I MVA- Brachyury -TRICOM CC Protocol #: 14-C-0142 OSP#: 1404-1301 Version Date: September 14, 2016 IBC#: RD -14-V-01 Amendment : C Title: An open- label phase I study to evaluate the safety and tolerability of a modified vaccinia Ankara (MVA) -based vaccine modified to express brachyury and T -cell costimulatory molecules (MVA -brachyury -TRICOM) NCI Principal Investigator: James L. Gulley, MD, PhD A, B, C, D, E, F Genitourinary Malignancies Branch National Cancer Institute 10 Center Drive Building 10, Room 12N226 Bethesda, MD 20892 Phone: (301) 496-4916 Fax: (301) 480-5094 Email: gulleyj@mail.nih.gov NIH Associate Investigators: Ravi A.